LTS LOHMANN Therapie-Systeme AG, a pharmaceutical technology company is acquiring Renaissance Lakewood, LLC, a U.S.-based CDMO specializing in nasal sprays and sterile dosage forms. The transaction is expected to close before end of November 2025, subject to regulatory approvals.

With the acquisition, Renaissance facilities will become part of LTS’ worldwide operations network, joining existing facilities in West Caldwell, NJ, St. Paul, MN, Andernach, Germany, and Netanya, Israel.

The acquisition is part of LTS’s strategy to expand its capabilities in the CDMO space. Renaissance brings expertise, state-of-the-art manufacturing infrastructure, and a skilled workforce of approximately 500 employees. This move enables LTS to offer a broader range of drug delivery solutions and strengthens CDMO capabilities.

Renaissance, headquartered in Lakewood, NJ, operates multiple manufacturing suites for unit-dose, bi-dose, multi-dose nasal sprays, and small-volume parenteral fill-finish vials. Its labs support R&D formulation development and spray characterization, from development through commercial launch.

Bas van Buijtenen, CEO of LTS, said, “This acquisition marks a significant step in our strategy to expand our CDMO capabilities and strengthen our position as a global leader in innovative drug delivery solutions. Renaissance’s expertise in nasal sprays and sterile dosage forms perfectly complements our existing portfolio and will enable us to offer even greater value to our partners and patients worldwide. We look forward to working together to drive innovation and deliver high-quality solutions across a broader range of therapeutic modalities.”

Serge Maltais, President & CEO of Renaissance added, “I am incredibly proud of what we have built at Renaissance thanks to the hard work and dedication of our employees. Now, as part of the LTS family, our combined strengths will position us even better to meet the complex needs of our clients and deliver greater value to the industry. We are excited to begin this new chapter and look forward to achieving success together.”